Analystreport

IntelliPharmaCeutics (NASDAQ: IPCI) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com